Loading data
CTORNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Research and development expense | 6.42 m USD | 4.93 m USD | — | 4.24 m USD | — |
| Operating profit | -23.52 m USD | -20.57 m USD | -1.01 m USD | — | -138.12 k USD |
| Interest expense | 218.03 k USD | — | — | — | — |
| Profit before tax | -23.7 m USD | -20.57 m USD | — | -12.12 m USD | — |
| Income tax expense | 1.06 m USD | 576 k USD | — | 576 k USD | — |
| Net income (reported basis) | -24.76 m USD | -21.15 m USD | 2.42 m USD | -12.7 m USD | 380.81 k USD |
| Basic earnings per share | -0.34 USD/share | -0.31 USD/share | 0.27 USD/share | -0.19 USD/share | 0.12 USD/share |
| Diluted earnings per share | -0.34 USD/share | -0.31 USD/share | 0.27 USD/share | -0.19 USD/share | 0.12 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.